University of Alabama at Birmingham
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Alabama at Birmingham sits in the top decile of US sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count).
University of Alabama at Birmingham: 1,160 sponsored US clinical trials, 216 recruiting.
University of Alabama at Birmingham sponsors 1,160 registered US clinical trials on ClinicalTrials.gov, 216 of them currently recruiting, and 723 completed. 97 of these trials are in Phase 3-4 (later-stage) and 259 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 15 trials.
Top-decile sponsor footprint
University of Alabama at Birmingham ranks in the top decile of sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
723 of 812 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,160 total, page 8 of 24
Comparison of Sacral Interface Pressure in Healthy Volunteers on Two Dynamic Pressure-Prevention Support Surfaces
NCT06661954
Weight Inclusive and Adaptive Strategies to Enhance Cardiometabolic Health in Black Adults
NCT06284681
Teaching Young Children Swim Survival Skills
NCT05977530
A Community Health Worker Intervention to Address Adverse Pregnancy Outcomes
NCT06353256
Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Department
NCT06229353
Virtual Reality Gaming for Exercise and Mindfulness Among Pediatric Cancer Rehabilitation
NCT06298357
Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1)
NCT06193174
Medical Nutrition Therapy and Diabetes Self-Management Education for People With Disabilities
NCT06049225
A Person-Centered Geotagged Social Networking System to Promote Physical Activity in the Community
NCT05216393
PrEP US NoW: PrEP Utilization Through Increasing Social Capital Among YBMSM Networks With Women
NCT07024745
Effect of Sublingually Generated S-nitroso-N-acetylcysteine on Systemic Blood Pressure.
NCT05798481
Feasibility Trial of a Stakeholder-enhanced Lay-navigator-delivered Intervention (ImPart-Multi)
NCT06067009
An Investigator Initiated Open Label Study Evaluating the Efficacy and Tolerability of Oral Deucravacitinib for the Treatment of Nail Psoriasis
NCT05124080
An Accessible and Inclusive Artificial Intelligence Assisted Chronic Disease Self-Management Telehealth Platform
NCT05481593
Promoting Resilience in Women With Breast Cancer
NCT06133348
An Exercise Intervention to Improve Overall Brain Health
NCT06035094
Clinical Reporting to Alleviate the Nocebo Effect
NCT06103474
Yogic Breathing Exercise for People With Amyotrophic Lateral Sclerosis
NCT05979688
Feasibility of An Active Video Gaming Intervention
NCT05310279
Improving the Cardiovascular Health of High-Risk Families Through an Innovative Home Visitation Intervention
NCT05839691
Combining VNS With PT Interventions for Individuals With PD
NCT05871151
Safety and Efficacy of Venetoclax in Idiopathic Pulmonary Fibrosis
NCT05976217
Piloting Movement-to-Music With Arm-based Sprint-Intensity Interval Training Among Children With Physical Disabilities
NCT05619211
Feasibility of Meal Delivery Postpartum
NCT05579990
Investigating the Use of taVNS to Treat Insomnia in Individuals With Breast Cancer (taVNS-insomnia-BC)
NCT06006299
PrEP4Her: Developing a Novel Strategy to Implement PrEP Into Women's Healthcare
NCT07209722
Virtual Reality Exercise in a Community Highschool for Children With Disabilities
NCT05935982
The Effects of Mirror-Based Virtual Reality Systems and Recalibration Software on Upper Extremity Function in Individuals Experiencing Hemiparesis Post-Stroke
NCT05856669
Increasing Movement and Exercise in Geriatric Patients Through Large-Scaled Creative Occupation Interventions
NCT05801445
ACT for Healthy Living: a Brief Acceptance and Commitment Therapy Intervention for Women With Obesity
NCT05885438
Phase 1 Study of the Pharmacokinetics of Amoxicillin in Pregnancy
NCT05309928
Virtual Reality-Base Intelligent Orientation and Mobility Specialists Trial
NCT04639531
Biopsychosocial Outcomes of Mindfulness-based Instruction
NCT05787483
A New Training to Enhance Physical Activity in Adolescents With Cerebral Palsy
NCT05865418
Providing an Optimized and emPowered Pregnancy for You (PᵌOPPY) Feasibility Study
NCT05940688
Identifying Ideal Reimbursement "Dose" to Reduce Clinical Trial-related Financial Toxicity
NCT05871125
Tolerability, Acceptance, and Utility of Intermittent CGM Use in Youth With Prediabetes
NCT05505565
Mindfulness-Based Diabetes Education for Adults With Elevated Diabetes Distress
NCT05195138
GODART Pilot and Feasibility
NCT05344859
Bradycardia Recognition and Detection in Young Infants Part-I
NCT05774470
Multi-component Intervention to Train Providers to Promote PrEP for Girls and Women in the Deep South
NCT06487390
Continuous Glucose Monitoring (CGM) in Kidney-Transplanted Adults
NCT05352230
Randomized Control Trial: Elbow Extension Versus Flexion Cast in Proximal Half Both Bone Forearm Fractures
NCT05470257
The Mental Health Experiences of Sexual and Gender Minorities Living With Cancer and Their Care Partners
NCT05866705
The Effect of SKY Breath Meditation on Health and Well-being
NCT05523414
Vestibular Balance Therapy Intervention for Children
NCT05741515
Smart Trainer Arm Ergometry Exercise Training in Individuals Post-Stroke
NCT05410600
Acceptance and Commitment Therapy for Depressed Individuals Living With Spinal Cord Injury Sustained Within 5 Years
NCT05725161
Testing the Efficacy and Mechanisms of an Adapted Resilience Building Intervention in People Aging With HIV
NCT05314088
Durvalumab and Tremelimumab With Platinum-based Chemotherapy in Intrahepatic Cholangiocarcinoma (ICC)
NCT04989218
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 129 |
| Phase 2 | 130 |
| Phase 3 | 25 |
| Phase 4 | 72 |
Therapeutic Areas
What is open in the University of Alabama at Birmingham pipeline
216 recruiting of 1,160 indexed (19% open); 723 completed (62%).
Phase mix: 97 late (III/IV) vs 259 early (I/II) (early-phase heavy).
Top condition: Obesity (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Alabama at Birmingham: open-pipeline peers nationwide
Peers matched on 1,160 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Alabama at Birmingham sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,160 trials (± recruiting share)
- NYU Langone Health · 1,164 trials · 17% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- Northwestern University · 1,209 trials · 15% recruiting
Sponsors near 19% open enrollment (± trial volume)
- University of Minnesota · 19% recruiting · 966 trials
- Mclean Hospital · 19% recruiting · 140 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
Related
What to do with this University of Alabama at Birmingham page
1,160 registered trials is a research-attention snapshot, not an endorsement of University of Alabama at Birmingham or any single study.
- 216 of University of Alabama at Birmingham's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Alabama at Birmingham studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Alabama at Birmingham pipeline card: 1,160 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.